KR20230078690A - 가스트린 방출 펩타이드 수용체 길항제를 포함하는 접합체 또는 이의 염 및 이의 용도 - Google Patents

가스트린 방출 펩타이드 수용체 길항제를 포함하는 접합체 또는 이의 염 및 이의 용도 Download PDF

Info

Publication number
KR20230078690A
KR20230078690A KR1020237011366A KR20237011366A KR20230078690A KR 20230078690 A KR20230078690 A KR 20230078690A KR 1020237011366 A KR1020237011366 A KR 1020237011366A KR 20237011366 A KR20237011366 A KR 20237011366A KR 20230078690 A KR20230078690 A KR 20230078690A
Authority
KR
South Korea
Prior art keywords
conjugate
mice
chelator
radionuclide
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237011366A
Other languages
English (en)
Korean (ko)
Inventor
줄리언 토르그
타니아 스탈론스
에이미 웡
아말 사이디
Original Assignee
오라노 메드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오라노 메드 filed Critical 오라노 메드
Publication of KR20230078690A publication Critical patent/KR20230078690A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020237011366A 2020-09-28 2021-09-22 가스트린 방출 펩타이드 수용체 길항제를 포함하는 접합체 또는 이의 염 및 이의 용도 Pending KR20230078690A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306109.8 2020-09-28
EP20306109.8A EP3973999A1 (en) 2020-09-28 2020-09-28 Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof
PCT/EP2021/076107 WO2022063850A1 (en) 2020-09-28 2021-09-22 Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof

Publications (1)

Publication Number Publication Date
KR20230078690A true KR20230078690A (ko) 2023-06-02

Family

ID=74180915

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237011366A Pending KR20230078690A (ko) 2020-09-28 2021-09-22 가스트린 방출 펩타이드 수용체 길항제를 포함하는 접합체 또는 이의 염 및 이의 용도

Country Status (21)

Country Link
US (1) US20230372552A1 (cg-RX-API-DMAC7.html)
EP (2) EP3973999A1 (cg-RX-API-DMAC7.html)
JP (1) JP7824281B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230078690A (cg-RX-API-DMAC7.html)
CN (1) CN116322798A (cg-RX-API-DMAC7.html)
AU (1) AU2021348219A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023003690A2 (cg-RX-API-DMAC7.html)
CA (1) CA3189680A1 (cg-RX-API-DMAC7.html)
DK (1) DK4188457T3 (cg-RX-API-DMAC7.html)
ES (1) ES2989009T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188457T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241285T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068360T2 (cg-RX-API-DMAC7.html)
IL (1) IL300486A (cg-RX-API-DMAC7.html)
LT (1) LT4188457T (cg-RX-API-DMAC7.html)
PL (1) PL4188457T3 (cg-RX-API-DMAC7.html)
PT (1) PT4188457T (cg-RX-API-DMAC7.html)
RS (1) RS65994B1 (cg-RX-API-DMAC7.html)
SI (1) SI4188457T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400392T1 (cg-RX-API-DMAC7.html)
WO (1) WO2022063850A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025163082A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2026150109A1 (en) 2025-01-10 2026-07-16 Molecular Partners Ag Mesothelin-specific binding constructs and their use in radiotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2100900A1 (en) 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
US20150217006A1 (en) * 2014-02-06 2015-08-06 Immunomedics, Inc. Al-f-18-labeled, al-f-19-labeled and ga-68-labeled gastrin-releasing peptide receptor (grpr)-antagonists for imaging of prostate cancer
CA3050094C (en) 2017-01-12 2024-01-02 Radiomedix Inc. Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes

Also Published As

Publication number Publication date
EP4188457B1 (en) 2024-07-03
CN116322798A (zh) 2023-06-23
EP3973999A1 (en) 2022-03-30
EP4188457A1 (en) 2023-06-07
ES2989009T3 (es) 2024-11-25
JP7824281B2 (ja) 2026-03-04
PL4188457T3 (pl) 2025-01-07
AU2021348219A1 (en) 2023-03-09
WO2022063850A1 (en) 2022-03-31
LT4188457T (lt) 2024-12-27
SI4188457T1 (sl) 2025-01-31
SMT202400392T1 (it) 2024-11-15
HUE068360T2 (hu) 2024-12-28
JP2023542218A (ja) 2023-10-05
RS65994B1 (sr) 2024-10-31
BR112023003690A2 (pt) 2023-04-04
CA3189680A1 (en) 2022-03-31
DK4188457T3 (da) 2024-08-26
IL300486A (en) 2023-04-01
HRP20241285T1 (hr) 2025-01-03
US20230372552A1 (en) 2023-11-23
FI4188457T3 (fi) 2024-09-23
PT4188457T (pt) 2024-09-10

Similar Documents

Publication Publication Date Title
JP7358430B2 (ja) Grpr陽性ガンの検出、診断及び治療のためのgrprアンタゴニスト
US5804157A (en) Peptide compositions and method of radiolabeling
DE69535242T2 (de) Somatostatin bindende peptide-metallchelat konjugate
TWI893557B (zh) 一種靶向sstr2的化合物及其製備方法和應用
AU2011333948A1 (en) 177 Lutetium-labeled bombesin analogs for radiotherapy
CN114364690A (zh) 用于诊断和治疗的新型放射性标记的cxcr4靶向化合物
EP4188457B1 (en) Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof
US20240100202A1 (en) Psma-targeting conjugate and uses thereof
WO2026058257A1 (en) Grpr binding peptides
RU2821944C2 (ru) Антагонисты grpr для обнаружения, диагностики и лечения grpr-позитивного онкологического заболевания
WO2024046469A1 (zh) 环肽及其制备方法、包括其的复合物、及其用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230403

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240919

Comment text: Request for Examination of Application